Cargando…

Bone metastasis risk factors in breast cancer

Bone is the single most frequent site for bone metastasis in breast cancer patients. Patients with bone-only metastasis have a fairly good prognosis when compared with patients with visceral disease. Nevertheless, cancer-induced bone disease carries an important risk of developing skeletal related e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pulido, Catarina, Vendrell, Inês, Ferreira, Arlindo R, Casimiro, Sandra, Mansinho, André, Alho, Irina, Costa, Luís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295847/ https://www.ncbi.nlm.nih.gov/pubmed/28194227 http://dx.doi.org/10.3332/ecancer.2017.715

Ejemplares similares

Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?
por: Casimiro, Sandra, et al.
Publicado: (2016)

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019)

The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
por: Ferreira, Arlindo, et al.
Publicado: (2016)

Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases
por: Ferreira, A.R., et al.
Publicado: (2017)

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
por: Lobo-Martins, Soraia, et al.
Publicado: (2020)

Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer
por: Vendrell, Ines, et al.
Publicado: (2018)

Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer
por: Gomes, Inês, et al.
Publicado: (2023)

Modelling cancer outcomes of bone metastatic patients: combining survival data with N-Telopeptide of type I collagen (NTX) dynamics through joint models
por: Loureiro, Hugo, et al.
Publicado: (2019)

The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
por: Gomes, Inês, et al.
Publicado: (2023)

RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro
por: Casimiro, Sandra, et al.
Publicado: (2013)

Exploring new pathways in endocrine-resistant breast cancer
por: de Pinho, Inês Soares, et al.
Publicado: (2022)

Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer
por: Gomes, Inês, et al.
Publicado: (2020)

Low Molecular Weight Protein Tyrosine Phosphatase Isoforms Regulate Breast Cancer Cells Migration through a RhoA Dependent Mechanism
por: Alho, Irina, et al.
Publicado: (2013)

RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells
por: Casimiro, S., et al.
Publicado: (2013)

c-Met expression in renal cell carcinoma with bone metastases
por: Silva Paiva, Rita, et al.
Publicado: (2020)

Bone Metastasis Prognostic Factors in Breast Cancer
por: Yazdani, Akram, et al.
Publicado: (2019)

Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization
por: Peixoto, Carolina, et al.
Publicado: (2023)

Treatment of Cancer Pain by Targeting Cytokines
por: Vendrell, I., et al.
Publicado: (2015)

Clinicopathological characteristics and prognostic risk factors of breast cancer patients with bone metastasis
por: Pan, Yuanxing, et al.
Publicado: (2021)

Simultaneous Gastric and Colonic Metastasis of Breast Cancer
por: Botto, Inês, et al.
Publicado: (2023)

Breast cancer–secreted factors perturb murine bone growth in regions prone to metastasis
por: Chiou, Aaron E., et al.
Publicado: (2021)

The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)

Prognostic Factors for Patients with Bone-Only Metastasis in Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Breast cancer metastasis to the bone: mechanisms of bone loss
por: Chen, Yu-Chi, et al.
Publicado: (2010)

Bone Targeted Therapies for Bone Metastasis in Breast Cancer
por: Razaq, Wajeeha
Publicado: (2013)

Risk factors for bone metastasis from renal cell cancer
por: Chen, Xuan-Yin, et al.
Publicado: (2017)

Treatment optimization of locally advanced and metastatic pancreatic cancer (Review)
por: Barros, Anabela G., et al.
Publicado: (2021)

The unresolved role of systemic factors in bone metastasis
por: Ubellacker, Jessalyn M., et al.
Publicado: (2016)

Risk of metastasis among rib abnormalities on bone scans in breast cancer patients
por: Li, Qin, et al.
Publicado: (2015)

The role of megakaryocytes in breast cancer metastasis to bone
por: Stiffin, Rose Mary, et al.
Publicado: (2011)

Implications of Hypoxia in Breast Cancer Metastasis to Bone
por: Gilkes, Daniele M.
Publicado: (2016)

The role of osteoclasts in breast cancer bone metastasis
por: Le Pape, François, et al.
Publicado: (2016)

Osthole inhibits bone metastasis of breast cancer
por: Wu, Chunyu, et al.
Publicado: (2017)

The Endosteal Niche in Breast Cancer Bone Metastasis
por: Haider, Marie-Therese, et al.
Publicado: (2020)

Meningioma Mimicking Bone Metastasis in Breast Cancer
por: Şahin, Oğuzhan, et al.
Publicado: (2023)

Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
por: Fernández Vallone, Valeria, et al.
Publicado: (2023)

Involvement of a Transcription factor, Nfe2, in Breast Cancer Metastasis to Bone
por: Zhang, Di, et al.
Publicado: (2020)

Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
por: Alves da Costa, Filipa, et al.
Publicado: (2023)

Influence of Psychological Factors in Breast and Lung Cancer Risk – A Systematic Review
por: Pereira, Maria Angelina, et al.
Publicado: (2022)

Treatment of early-stage HER2+ breast cancer—an evolving field
por: Ferreira, Arlindo R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1kjiaa8t0jn5312fthkrhsobml